Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Tags:
Pharmacyclics, ibrutinib, blood cancer, JNJ, AbbVie
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Forbes
Sat, 07/13/13 - 12:04 pm
Tags:
JNJ
Johnson & Johnson Earnings Are on Deck
Motley Fool
Fri, 07/12/13 - 07:33 am
Tags:
earnings, JNJ
Laywer Spars With FDA Over J&J Risperdal Court Documents
Pharmalot
Thu, 07/11/13 - 12:10 pm
Tags:
FDA, JNJ, Risperdal
Astex Pharmaceuticals In Focus With Catalyst In The Near Term
Seeking Alpha
Thu, 07/11/13 - 11:15 am
Tags:
Astex, AstraZeneca, Celgene, GSK, JNJ, Novartis, SGI-110, Dacogen
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
Tags:
breakthrough therapies, ibrutinib, Pharmacyclics, JNJ, chronic lymphocytic leukemia
How Johnson & Johnson Revamped its Executive Pay Practices
Forbes
Wed, 07/10/13 - 01:31 pm
Tags:
JNJ, executive pay
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
Tags:
JNJ, Pharmacyclics, ibrutinib, chronic lymphocytic leukemia
Johnson & Johnson, Merck Facing Biosimilar Threat
Seeking Alpha
Fri, 07/5/13 - 10:35 am
Tags:
Merck, JNJ, biosimilars, Hospira, Celltrion
In Pursuit of Healthcare, Buying Time - A 21st Century Declaration
Forbes
Thu, 07/4/13 - 11:15 am
Tags:
Warren Buffett, GSK, Affordable Care Act, JNJ, DaVita
Is This Pharmaceutical Giant About To Lose Its Cornerstone Drug?
Motley Fool
Wed, 07/3/13 - 11:50 am
Tags:
Celltrion, Hospira, Remicade, JNJ
Glaxo J&J Combination May Control HIV With Monthly Injections
Bloomberg
Wed, 07/3/13 - 11:05 am
Tags:
GSK, JNJ, HIV, GSK744, TMC278
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Tags:
Eli Lilly, diabetes, dulaglutide, JNJ, Merck, Novo Nordisk, Bristol-Myers Squibb
J&J's pharma chairman lands 'more deals' in Boston innovation push
Fierce Biotech
Thu, 06/27/13 - 11:58 am
Tags:
JNJ, Boston, innovation, Rodin Therapeutics, Vedanta Biosciences
Eli Lilly Wins U.K. Patent Suit on J&J Alzheimer’s Research
Bloomberg
Tue, 06/25/13 - 11:25 am
Tags:
Eli Lilly, UK, patents, JNJ, Alzheimer's disease
Why Might This Play Shake Up the Cancer-Drug Industry?
Motley Fool
Tue, 06/25/13 - 10:41 am
Tags:
cancer, JNJ, M&A, Aragon, prostate cancer
This Week in Biotech
Motley Fool
Sun, 06/23/13 - 11:11 am
Tags:
Nektar, NKTR-181, pain management, Novartis, serelaxin, Idenix, IDX20963, hepatitis C, ViroPharma, JNJ, Aragon, ARN-509, prostage cancer
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thu, 06/20/13 - 07:46 am
Tags:
Infinity Pharmaceuticals, JNJ, Pharmacyclics, Gilead, non-Hodgkin's lymphoma, ibrutinib, Idelalisib, IPI-145
J&J issued FDA warning letter on Xarelto advertising
The Fly on the Wall
Wed, 06/19/13 - 03:49 pm
Tags:
JNJ, FDA, Xarelto, warnings
Medivation retreats after J&J beefs up prostate cancer slate
The Fly on the Wall
Mon, 06/17/13 - 12:37 pm
Tags:
JNJ, M&A, Medivation, prostate cancer, Aragon, Zytiga

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.